Showing results (201-210 of 294) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural MesotheliomaMarjorie G Zauderer, Anne S Tsao, Tao Dao, et al.
Stem Cell Reports|February 12, 2021
Apple Peel and Flesh Contain Pro-neurogenic CompoundsMuhammad Ichwan, Tara L Walker, Zeina Nicola, et al.
The Lancet. Respiratory Medicine|May 13, 2024
Leveraging the pleural space for anticancer therapies in pleural mesotheliomaKevin G Blyth, Prasad S Adusumilli, Philippe Astoul, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 29, 2022
Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinomaCaitlin A Harrington, Rebecca A Carr, Meier Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks AnalysisTakashi Eguchi, Sarina Bains, Ming-Ching Lee, et al.
NPJ Precision Oncology|July 22, 2021
Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinomaRaul Caso, James G Connolly, Jian Zhou, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 27, 2024
Characterizing a learning curve for robotic-assisted bronchoscopy: Analysis of skills acquisition in a high-volume academic centerMatthew J Bott, Nicolas Toumbacaris, Kay See Tan, et al.
The Annals of Thoracic Surgery|March 19, 2018
Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable TumorsMatthew J Bott, Jonathan Cools-Lartigue, Kay See Tan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural MesotheliomaYan Li, Soo-Ryum Yang, Ying-Bei Chen, et al.
Oncotarget|May 7, 2016
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinomaTakashi Eguchi, Kyuichi Kadota, Jamie Chaft, et al.
Pageof 30